TMC Life Sciences Berhad reported unaudited consolidated earnings results for the six months ended November 30, 2016. For the quarter, the company reported revenue of MYR 36,202,000 against MYR 31,332,000 a year ago. Profit from operations was MYR 6,587,000 against MYR 5,408,000 a year ago. Profit before taxation was MYR 6,105,000 against MYR 4,883,000 a year ago. Profit attributable to owners of the parent was MYR 4,439,000 or 0.17 sen per diluted share against MYR 3,338,000 or 0.21 sen per diluted share a year ago. Higher revenue was mainly due to higher patient load supported by additional bed capacity, additional consultants recruited and higher growth in fertility business. Profitability improved due to higher revenue recorded and interest income earned. For the six months, the company reported net cash flows from operating activities were MYR 5,769,000 against MYR 15,187,000 a year ago. Acquisition of property plant and equipment was MYR 6,176,000 against MYR 9,350,000 a year ago.